Oral buccal tablet for later-period regulation of chronic bronchitis

Abstract

The invention discloses an oral buccal tablet for later-period regulation of chronic bronchitis. The total composition of the oral buccal comprises medical components with the weight ratio being 9%-20% and the effect of killing pyogenic coccus and bacillus; the medical components are extracts of euphorbia pekinensis, violae, notopterygium root and galanga; in the total composition of the buccal tablet, the weight percent of the euphornin is more than or equal to 0.01%, the weight percent of flavonoid glycosides is more than or equal to 0.01%, the weight percent of the columbianetin is more than or equal to 0.02%, and the weight percent of methyl cinnamate is more than or equal to 0.008%. The oral buccal tablet disclosed by the invention has the advantages that pathogenic bacterium of nasosinusitis in an oral cavity can be effectively killed and the pathogenic bacterium in the oral cavity can be prevented from infecting the bronchia.

Description

technical field [0001] The invention relates to an oral buccal tablet for regulating the late stage of chronic bronchitis. Background technique [0002] Oral hygiene products are indispensable cleaning products in people's daily life. There are many kinds of products in this category, including lozenges, tooth powders, oral cleaners, etc., which are mainly used to keep the mouth clean, promote fresh breath, and maintain a good oral environment. But so far, there is not yet an oral lozenge that is used for the later stage of chronic bronchitis. [0003] Chronic bronchitis (abbreviated as chronic bronchitis) refers to chronic non-specific inflammation of the trachea, bronchial mucosa and surrounding tissues. Clinically, it is characterized by a chronic process of cough, sputum production, or accompanied by wheezing and recurrent attacks. It is a common disease that seriously endangers people's health, especially in the elderly. [0004] At the same time, chronic bronchitis ...

AI Technical Summary

Problems solved by technology

The oral cavity and the trachea communicate with each other, and pathogenic bacteria will spread between the two. The existing treatment method simply uses antibiotics to kill the pathogenic bacteria, but does not kill the pathogenic bacteria in the oral cavity. When the pathogenic bacteria in the bronchi When killing, the pathogenic bacteria in the oral cavity will infect it repeatedly, resulting in chronic bronchitis that cannot be cured for a long time

[0006] At present, there is no oral lozenge on the market for the late stage conditioning of chronic bronchitis